The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Simmons & Simmons

CITYPOINT, ONE ROPEMAKER STREET, LONDON, EC2Y 9SS, ENGLAND
Tel:
Work +44 20 7628 2020
Fax:
Fax +44 20 7628 2070
DX:
12 LONDON CHANCERY
Email:
Web:
www.simmons-simmons.com

Scott Parker

Tel:
Work 020 7825 3070
Email:
Simmons & Simmons

Position

Scott specialises in contentious and non-contentious intellectual property generally, with a strong emphasis on patent litigation in the pharmaceutical, biotechnology and medical device industries. He has considerable experience of defending the patents of research based pharmaceutical companies against attack by their generic competitors and coordinating with the legal teams in other jurisdictions. He has also advised on patent disputes in other industry sectors and in proceedings for design right infringement and misuse of confidential information. Scott is regularly instructed to give patent validity and infringement opinions and also advises clients on licensing and other commercial agreements.

Career

Qualified 2000; partner 2012; has written articles on patent and licensing matters, and published several scientific papers.

Education

MA in Biochemistry; MSc in Biological Chemistry; University of Michigan (two years studying HIV transcription); 2001 diploma in Intellectual Property Law and Practice.


London: TMT (technology, media and telecoms)

Pharmaceuticals and biotechnology

Within: Pharmaceuticals and biotechnology

Simmons & Simmons is 'jam-packed full of the highest-calibre individuals' in the areas of transactions, patent litigation and regulations. Michael Gavey leads the team and is particularly prominent in handling the IP aspects of transactions. Charles Mayo is also a key figure and highly experienced in M&A and capital markets transactions. Other key members of the team include Scott Parker, who is an expert in patent litigation, and transactions specialist Lydia Torne. Rowan Freeland has retired.

[back to top]


Back to index

Legal Developments by:
Simmons & Simmons

  • Failure to counter financial crime: Norwich Union Life

    In December 2007, the Financial Services Authority (FSA) imposed a fine of £1.26m on Norwich Union Life (part of the Aviva Group), one of the largest life insurance businesses in the UK with around seven million customers. The fine related to failures to take reasonable care to establish and maintain effective systems and controls for countering the risks of financial crime. The fine is the latest confirmation of the emphasis being placed on protecting clients and customers from the threat of financial crime.
    - Simmons & Simmons

Legal Developments in London

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to